Skip to content

Clinical trials

Vulvar Neoplasms trials in China

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Vulvar Neoplasms Country / region: China Clear all

21 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20181
20191
20204
20212
20225
20235
20242
20261

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed7
Recruiting7
Unknown status4
Active, not recruiting2
Terminated1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Shanghai Bovax Biotechnology Co., Ltd.5
Beijing Health Guard Biotechnology, Inc3
HRYZ Biotech Co.2
Sichuan Enray Pharmaceutical Sciences Company2
Zhejiang Cancer Hospital2
Akeso1
Liu Zi1
Peking Union Medical College Hospital1
Shanghai Zerun Biotechnology Co.,Ltd1
The Affiliated Hospital of Qingdao University1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Vulvar Neoplasms21
Uterine Cervical Neoplasms17
Vaginal Neoplasms15
Condylomata Acuminata8
Anus Neoplasms6
Papillomavirus Infections6
Ovarian Neoplasms3
Penile Neoplasms3
Colorectal Neoplasms2
Endometrial Neoplasms2

Trials

Showing 51 to 21 of 21. Each trial links to its page on Pharma Observatory.

No trials match these filters.

Try a different keyword, or clear a filter.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.